Skip to main content
Premium Trial:

Request an Annual Quote

Lawrence Tech University Lands $3M Gift for Life Sciences and Molecular Medicine Institute

NEW YORK (GenomeWeb News) – Lawrence Technological University in southeastern Michigan has received an anonymous $3 million gift to expand its life sciences program, to fund research programs and establish an institute of molecular medicine, and to support research programs that include functional proteomics studies of type II diabetes, LTU said Monday.
 
LTU biology Professor Hsiao-Ping Moore, who studies proteomics and cell signaling, is planning the expansion, LTU said.
 
Separately, Moore is using federal funds in a collaboration with Wayne State University scientist James Granneman to study the proteins involved in the links between type II diabetes and obesity. That research is supported by the National Institutes of Health, the American Diabetes Association, and Veterans Administration Hospitals.
 
In addition to the anonymous gift, which LTU said it received this summer, the university also will use a $1 million endowment to support the life sciences and biomedical engineering expansion.
 
LTU was not immediately available to provide more information about the origin of the anonymous gift or the endowment, or more specifics about its planned molecular medicine institute.

The Scan

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.

Sequencing Study Leads to Vaccine Target in Bacteria Behind Neonatal Meningitis

Researchers eBioMedicine track down potential vaccine targets with transposon sequencing on mutant bacteria causing neonatal meningitis in mouse models of the disease.

Multiple Myeloma Progression Influenced by Immune Microenvironment Expression

Researchers in NPJ Genomic Medicine compare RNA sequencing profiles of 102,207 individual cells in bone marrow samples from 18 individuals with rapid or non-progressing multiple myeloma.

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.